Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?

Reflections
Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?
Like

Volume 113, Issue 1, Pages 87–88

Authors:

Sushila Arya, M.D., Karl R. Hansen, M.D., Ph.D., Robert A. Wild, M.D., M.P.H., Ph.D.

Abstract:

Reflections on "Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial" by Li et al.


Read the full text here.

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.